Impaired quality of life, disability and mental health in Takayasu's arteritis

Rheumatology (United Kingdom)

Volumn 52, Issue 10, 2013, Pages 1898-1904

  Yilmaz, Neslihan ^a   Can, Meryem ^a   Oner, Fatma Alibaz ^a   Kalfa, Melike ^b   Emmungil, Hakan ^b   Karadag, Omer ^c   Yildiz, Fatih ^d   Kimyon, Gezmis ^e   Yilmazer, Baris ^f   Gerdan, Vedat ^g   Bilge, Sule Yasar ^h   Ilhan, Birkan ^a   Cobankara, Veli ⁱ   Kasifoglu, Timucin ^h   Cefle, Ayse ^f   Kisacik, Bunyamin ^e   Onat, Ahmet Mesut ^e   Akar, Servet ^g   Onen, Fatos ^g   Erken, Eren ^d   Kiraz, Sedat ^c   Aksu, Kenan ^b   Keser, Gokhan ^b   Mumcu, Gonca ^a   Direskeneli, Haner ^a   more..

^a MARMARA UNIVERSITY   (Turkey)

^b EGE UNIVERSITY   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

^d CUKUROVA UNIVERSITY   (Turkey)

^e GAZIANTEP UNIVERSITY   (Turkey)

^f KOCAELI UNIVERSITY   (Turkey)

^g DOKUZ EYLUL UNIVERSITY   (Turkey)

^h ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

ⁱ PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

Function; Mental status; Quality of life; Takayasu's arteritis

Indexed keywords

ADULT; ANCA ASSOCIATED VASCULITIS; ANXIETY DISORDER; AORTA ARCH SYNDROME; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISABILITY; DISEASE ACTIVITY; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT FORM 36; SOCIAL STATUS;

EID: 84887352284     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket238     Document Type: Article

References (41)

1. Arend WP, Michel BA, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 1990;33:1129-34.
2. Lupi-Herrera E, Sánchez-Torres G, Marcushamer J et al. Takayasu's arteritis. Clinical study of 107 cases. Am Heart J 1977;93:94-103.
3. Bicakcigil M, Aksu K, Kamali S et al. Takayasu's arteritis in Turkey-clinical and angiographic features of 248 patients. Clin Exp Rheumatol 2009;27:59-64.
4. Scott DG, Watts RA. Takayasu's arteritis. EULAR on line course on rheumatic disease-2009; Module 23 (in depth discussion II) 2009;23:1-13.
5. Hotchi M. Pathological studies on Takayasu arteritis. Heart Vessels 1992;7:11-7.
6. Andrews J, Mason JC. Takayasu's arteritis-recent advances in imaging offer promise. Rheumatology 2007;46:6-15.
7. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-item Short-Form Health Survey (SF-36) II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-63.
8. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36) I. Conceptual framework and item selection. Med Care 1992;30:473-83.
9. Walsh M, Mukhtyar C, Mahr A et al. Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Care Res 2011;63:1055-61.
10. Mukhtyar C, Flossmann O, Hellmich B et al. Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism Systemic Vasculitis Task Force. Ann Rheum Dis 2008;67:1004-10.
11. Koutantji M, Harrold E, Lane SE et al. Investigation of quality of life, mood, pain, disability, and disease status in primary systemic vasculitis. Arthritis Rheum 2003;49:826-7.
12. Newall C, Schinke S, Savage CO et al. Impairment of lung function, health status and functional capacity in patients with ANCA-associated vasculitis. Rheumatology 2005;44:623-8.
13. Srouji IA, Andrews P, Edwards C et al. General and rhinosinusitis-related quality of life in patients with Wegener's granulomatosis. Laryngoscope 2006;116:1621-5.
14. Hoffman GS, Drucker Y, Cotch MF et al. Wegener's granulomatosis: patient-reported effects of disease on health, function, and income. Arthritis Rheum 1998;41:2257-62.
15. Akar S, Can G, Binicier O et al. Quality of life in patients with Takayasu's arteritis is impaired and comparable with rheumatoid arthritis and ankylosing spondylitis patients. Clin Rheumatol 2008;27:859-65.
16. Abularrage CJ, Slidell MB, Sidawy AN et al. Quality of life of patients with Takayasu's arteritis. J Vasc Surg 2008;1:131-7.
17. Arend WP, Michel BA, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 1990;33:1129-34.
18. Hata A, Noda M, Moriwaki R et al. Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol 1996;54(Suppl):155-63.
19. Kerr GS, Hallahan CW, Giordano J et al. Takayasu arteritis. Ann Intern Med 1994;120:919-29.
20. Pinar R. Reliability and construct validity of the SF-36 in Turkish cancer patients. Qual Life Res 2005;14:259-64.
21. Sprangers MA, de Regt EB, Andries F et al. Which chronic conditions are associated with better or poorer quality of life? J Clin Epidemiol 2000;5:895-907.
22. Ware JE Jr, Kosinski M, Bayliss MS et al. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the medical outcomes study. Med Care 1995;33:264-79.
23. Pincus T, Sokka T. Can a multi-dimensional health assessment questionnaire (MDHAQ) and routine assessment of patient index data (RAPID) scores be informative in patients with all rheumatic diseases? Best Pract Res Clin Rheumatol 2007;21:733-53.
24. Herrmann C. International experiences with the hospital anxiety and depression scale-a review of validation data and clinical results. J Psychosom Res 1997;42:17-41.
25. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70.
26. Direskeneli H, Aydin SZ, Merkel PA. Assessment of disease activity and progression in Takayasu's arteritis. Clin Exp Rheumatol 2011;29(1 Suppl 64):S86-91.
27. Direskeneli H, Aydin SZ, Kermani TA et al. Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda. J Rheumatol 2011;38:1471-9.
28. Aydin SZ, Yilmaz N, Akar S et al. Assessment of disease activity and progression in Takayasu's arteritis with Disease Extent Index-Takayasu. Rheumatology 2010;49:1889-93.
29. Merkel PA, Aydin SZ, Boers M et al. The OMERACT core set of outcome measures for use in clinical trials of ANCAassociated vasculitis. J Rheumatol 2011;38:1480-6.
30. Faurschou M, Sigaard L, Bjorner JB et al. Impaired healthrelated quality of life in patients treated for Wegener's granulomatosis. J Rheumatol 2010;37:2081-5.
31. Stone JH, Merkel PA, Spiera R et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 2010;363:221-32.
32. Srouji IA, Andrews P, Edwards C et al. Patterns of presentation and diagnosis of patients with Wegener's granulomatosis: ENT aspects. J Laryngol Otol 2007;121:653-8.
33. Reinhold-Keller E, Erlyn K, Wagner-Bastmeyer R et al. Effect of Wegener's granulomatosis on work disability, need for medical care, and quality of life in patients younger than 40 years at diagnosis. Arthritis Rheum 2002;47:320-5.
34. Tomasson G, Boers M, Walsh M et al. Assessment of health-related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener's). Arthritis Care Res 2012;64:273-9.
35. Kupersmith MJ, Speira R, Langer R et al. Visual function and quality of life among patients with giant cell (temporal) arteritis. J Neuroophthalmol 2001;21:266-73.
36. Hellmann DB, Uhlfelder ML, Stone JH et al. Domains of health-related quality of life important to patients with giant cell arteritis. Arthritis Rheum 2003;49:819-25.
37. Wolfe F, Michaud K, Strand V. Expanding the definition of clinical differences: from minimally clinically important differences to really important differences. Analyses in 8931 patients with rheumatoid arthritis. J Rheumatol 2005;32:583-9.
38. Bachen EA, Chesney MA, Criswell LA. Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus. Arthritis Rheum 2009;61:822-9.
39. Covic T, Cumming SR, Pallant JF et al. Depression and anxiety in patients with rheumatoid arthritis: prevalence rates based on a comparison of the Depression, Anxiety and Stress Scale (DASS) and the Hospital Anxiety and Depression Scale (HADS). BMC Psychiatry 2012;24:12-6.
40. Herlyn K, Hellmich B, Seo P et al. Patient-reported outcome assessment in vasculitis may provide important data and a unique perspective. Arthritis Care Res 2010;62:1639-45.
41. Hajj-Ali RA, Wilke WS, Calabrese LH et al. Pilot study to assess the frequency of fibromyalgia, depression and sleep disorders in patients with granulomatosis with polyangiitis (Wegener's). Arthritis Care Res 2011;63:827-33.